These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1955281)

  • 1. Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Int J Microcirc Clin Exp; 1991 Aug; 10(3):231-40. PubMed ID: 1955281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous oxygen pressure measured at two different electrode core temperatures in healthy volunteers and patients with arterial occlusive disease.
    Creutzig A; Dau D; Caspary L; Alexander K
    Int J Microcirc Clin Exp; 1987; 5(4):373-80. PubMed ID: 3557822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of transcutaneous PO2 and laser Doppler measurements in a human model of local arterial insufficiency.
    Matsen FA; Wyss CR; Robertson CL; Oberg PA; Holloway GA
    Surg Gynecol Obstet; 1984 Nov; 159(5):418-22. PubMed ID: 6495138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Klin Wochenschr; 1990 Feb; 68(4):207-12. PubMed ID: 2314008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The reproducibility of transcutaneous oxygen pressure by continuous registration].
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1992; 35():32-3. PubMed ID: 1481053
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of percutaneous transluminal angioplasty on transcutaneous oxygen pressure in patients with peripheral arterial occlusive disease.
    Wagner HJ; Schmitz R; Alfke H; Klose KJ
    Radiology; 2003 Mar; 226(3):791-7. PubMed ID: 12601207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcutaneous oxygen pressure (TcPO2): advantages and limitations].
    Got I
    Diabetes Metab; 1998 Sep; 24(4):379-84. PubMed ID: 9805653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle tissue PO2 during moderate altitude exposure in patients with peripheral arterial occlusive disease.
    Landgraf H; Schulte-Huermann D; Vallbracht C; Ehrly AM
    Presse Med; 1994 Feb; 23(4):164-8. PubMed ID: 8177858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of diabetes and lower limb arterial disease on cutaneous foot perfusion.
    Williams DT; Price P; Harding KG
    J Vasc Surg; 2006 Oct; 44(4):770-5. PubMed ID: 16930928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CO2-induced acral blood flow and the oxygen partial pressure in arterial occlusive disease].
    Hartmann B; Drews B; Bassenge E
    Dtsch Med Wochenschr; 1991 Oct; 116(43):1617-21. PubMed ID: 1935632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of transcutaneous oximetry (tcPO2) during oxygen inhalation and leg dependency in severe peripheral arterial occlusive disease.
    Scheffler A; Rieger H
    J Vasc Surg; 1992 Aug; 16(2):218-24. PubMed ID: 1495145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of leg and body position on transcutaneous oxygen measurements in healthy subjects and subjects with peripheral artery disease after lower-extremity arterial revascularization: a pilot study.
    Rich K
    J Vasc Nurs; 2002 Dec; 20(4):125-35; quiz 136-7. PubMed ID: 12469073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive determination of dermal hemoglobin oxygenation and concentration in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Stappler T; Alexander K
    Vasa; 1997; 26(1):11-7. PubMed ID: 9068263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcutaneous oxygen partial pressure and systolic malleolar artery pressure in patients with peripheral arterial occlusive disease. Longitudinal measurements over 14 days].
    Heidrich H; Lammersen T
    Med Klin (Munich); 1993 Oct; 88(10):564-7. PubMed ID: 8272016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of reactive hyperemia and leg dependency on skin microcirculation in patients with peripheral arterial occlusive disease (PAOD), with and without diabetes.
    Wahlberg E; Jörneskog G; Olofsson P; Swedenborg J; Fagrell B
    Vasa; 1990; 19(4):301-6. PubMed ID: 2291309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of transcutaneous oximetry in detection of diabetic microangiopathy in lower limbs].
    Wróblewski T; Starzyńska R
    Pol Tyg Lek; 1994 Apr 18-25; 49(16-17):376-8. PubMed ID: 7708557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transcutaneous and intracutaneous pO2 measurements in the assessment of peripheral arterial occlusive diseases].
    Reuter U; Setlak P; Petrow C; Altmann E; Sinz V
    Z Gesamte Inn Med; 1987 Apr; 42(7):178-82. PubMed ID: 3604349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of transcutaneous staged dynamic oximetry of stage II arteritis of the leg].
    Grard C; Desmytterre J; Vinckier L; Hatron PY; Roux JP; Warembourg H; Devulder B
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():51-7. PubMed ID: 2111687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.